BC-SeraPro, a simple, minimally invasive blood test for breast cancer, analyzes biomarkers, or specific proteins, in a woman’s blood serum, to detect breast cancer. In addition to providing the Middle East with a diagnostic test more suitable for their culture, the test will supplement the traditional mammography and MRI.
Essam Sheta, researcher at Power3 Medical, said: “We believe the test provides a promising alternative for the detection of breast cancer at its earlier stages, thereby alleviating the problems that so many Middle Eastern women face because of late-stage detection.”